These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 159153)

  • 1. [Serum dopamine-beta-hydroxylase, glutamic acid decarboxylase and 1-aromatic amino acid decarboxylase in involuntary movement disorders (author's transl)].
    Nakamura S; Miyata S; Kameyama M
    Rinsho Shinkeigaku; 1979 Aug; 19(8):511-4. PubMed ID: 159153
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of aromatic-L-amino acid decarboxylase by decarboxylase inhibitors in idiopathic parkinsonism.
    Boomsma F; Meerwaldt JD; Man in 't Veld AJ; Hovestadt A; Schalekamp MA
    Ann Neurol; 1989 Jun; 25(6):624-8. PubMed ID: 2742363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glutamic acid decarboxylase activity in normal dogs.
    Ayers JL; Ramsey FK; Vreeken E; Jowett D
    Am J Vet Res; 1978 Nov; 39(11):1802-4. PubMed ID: 736335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease.
    Lieberman AN; Freedman LS; Goldstein M
    Lancet; 1972 Jan; 1(7742):153-4. PubMed ID: 4109012
    [No Abstract]   [Full Text] [Related]  

  • 6. Glutamic-acid decarboxylase and choline acetylase in Huntington's chorea and Parkinson's disease.
    McGeer PL; McGeer EG; Fibiger HC
    Lancet; 1973 Sep; 2(7829):622-3. PubMed ID: 4125419
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical aspects of Parkinson's disease.
    Nagatsu T
    Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum dopamine-beta-hydroxylase in parkinsonism.
    Markianos ES; Rüther E
    J Neural Transm; 1977; 40(1):21-5. PubMed ID: 833581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, dopamine, and serotonin in the forebrain of Ambystoma mexicanum.
    Beltramo M; Pairault C; Krieger M; Thibault J; Tillet Y; Clairambault P
    J Comp Neurol; 1998 Feb; 391(2):227-47. PubMed ID: 9518271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma glutamate decarboxylase activity in neuropsychiatry.
    Kaiya H; Namba M; Yoshida H; Nakamura S
    Psychiatry Res; 1982 Jun; 6(3):335-43. PubMed ID: 6213971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical aspects of experimentally induced parkinsonism.
    Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
    [No Abstract]   [Full Text] [Related]  

  • 12. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
    Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
    Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional activities of metabolic enzymes and glutamate decarboxylase in human brain.
    Maker HS; Weiss C; Weissbarth S; Silides DJ; Whetsell W
    Ann Neurol; 1981 Oct; 10(4):377-83. PubMed ID: 7316490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of aromatic L-amino acid decarboxylase in goldfish (Carassius auratus) brain.
    Beltramo M; Krieger M; Tillet Y; Thibault J; Calas A; Mazzi V; Franzoni MF
    J Comp Neurol; 1994 May; 343(2):209-27. PubMed ID: 7913102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic and pharmacodynamic aspects of L-DOPA treatment and dopadecarboxilase inhibitors and dopaminergic antagonists in Parkinson's disease (author's transl)].
    García de Yébenes J; Avila C; Bazán E; García E; Gervás J; Maseda C; Mena M; Muradas V; Ramos JA
    Med Clin (Barc); 1982 Apr; 78(7):259-64. PubMed ID: 7087591
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
    Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine hydroxylase containing neurons lacking aromatic amino acid decarboxylase in the hamster brain.
    Vincent SR; Hope BT
    J Comp Neurol; 1990 May; 295(2):290-8. PubMed ID: 1972709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
    Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
    Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatic L-amino acid decarboxylase, dopamine beta-hydroxylase, monoamine oxidase, malondialdehyde, and acid phosphatase in rat brain capillaries and kidney glomeruli in experimental hypertension.
    Valli VV; Sadasivudu B
    J Neurosci Res; 1985; 13(4):481-8. PubMed ID: 4009739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on Huntington's disease. III. Biochemical observations, a possibly predictive test?
    Shokeir MH
    Clin Genet; 1975 Apr; 7(4):354-60. PubMed ID: 123839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.